RecallDepth
Class I Terminated

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

Company
Gilead Sciences, Inc.
Recall Initiated
January 31, 2013
Posted
May 22, 2013
Recall Number
D-324-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,181 vials
Firm Location
Foster City, CA, United States

Reason for Recall

Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).

Distribution

Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.

Lot / Code Info

Lot #: B120217A, Exp 05/15 - US Distribution

More recalls by Gilead Sciences, Inc.

View all recalls by this company →

Other recent Class I Drug recalls